Glycemic and weight changes after persistent use of incident oral diabetes therapy: A veterans administration retrospective cohort study

Pharmacoepidemiology and Drug Safety

Volumn 19, Issue 11, 2010, Pages 1108-1112

  Huizinga, Mary Margaret ^a,b   Roumie, Christianne L ^c,d   Greevy, Robert A ^c,d   Liu, Xulei ^c,d   Murff, Harvey J ^c,d   Hung, Adriana M ^c,d   Grijalva, Carlos G ^d   Griffin, Marie R ^c,d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c Clinical Research Center of Excellence (CRCoE)   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Comparative effectiveness; Diabetes; Oral antidiabetic agents

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; DIABETES CONTROL; DIABETES MELLITUS; DRUG EFFECT; DRUG USE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH CARE UTILIZATION; HUMAN; INCIDENT REPORT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT INFORMATION; PRESCRIPTION; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; RETROSPECTIVE STUDY; SIDE EFFECT; VETERAN; WEIGHT CHANGE; WEIGHT GAIN;

ADMINISTRATION, ORAL; AGED; BLOOD GLUCOSE; BODY MASS INDEX; BODY WEIGHT; COHORT STUDIES; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; MIDDLE AGED; RETROSPECTIVE STUDIES; SULFONYLUREA COMPOUNDS; TREATMENT OUTCOME; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; VETERANS;

EID: 78049265356     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.2035     Document Type: Article

References (14)

1. Complications of Diabetes in the United States. Vol. 2007: American Diabetes Association.
2. Draft Comparative Effectiveness Review Comparative Effectiveness and Safety of Diabetes Medications for Adults with Type 2 Diabetes. Vol. 2010: AHRQ, 2010.
3. Bolen S, Feldman L, Vassy J, et al., Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus. Ann Intern Med 2007; 147: 386-399.
4. Hynes DM, Koelling K, Stroupe K, et al., Veterans' access to and use of medicare and veterans affairs health care. Med Care 2007; 45: 214-223.
5. International Classification of Diseases, Ninth Revision, Clinical Modification. Washington, DC:: Public Health Service, US Dept of Health and Human Services, 1988.
6. Lin D, Wei L. The robust inference for the cox proportional hazards model. J Am Stat Assoc 1989; 84: 1074-1078.
7. Phung OJ, Scholle JM, Talwar M, Coleman CI. Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes. Jama; 2010; 303: 1410-1418.
8. Standards of medical care in diabetes-2009. Diabetes Care 2009; 32 (Suppl 1): S13-S61.
9. Duckworth W, Abraira C, Moritz T, et al., Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360: 129-139.
10. Gerstein HC, Miller ME, Byington RP, et al., Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545-2559.
11. Patel A, MacMahon S, Chalmers J, et al., Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560-2572.
12. DeFronzo RA. Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med 1999; 131: 281-303.
13. Rodbard HW, Jellinger PS, Davidson JA, et al., Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control. Endocr Pract 2009; 15: 540-559.
14. Grymonpre R, Cheang M, Fraser M, Metge C, Sitar DS. Validity of a prescription claims database to estimate medication adherence in older persons. Med Care 2006; 44: 471-477.